The role of premorbid transthoracic echocardiogram in identifying adverse clinical outcomes in patients admitted with COVID-19

MLA

M Ambrosino, et al. “The Role of Premorbid Transthoracic Echocardiogram in Identifying Adverse Clinical Outcomes in Patients Admitted with COVID-19.” European Heart Journal, vol. 42, Oct. 2021. EBSCOhost, https://doi.org/10.1093/eurheartj/ehab724.0103.

APA

M Ambrosino, N Patel, L Panepinto, S Denduluri, C Lee, M Byers, Marielle Scherrer-Crosbie, Srinath Adusumalli, & Jordana B. Cohen. (2021). The role of premorbid transthoracic echocardiogram in identifying adverse clinical outcomes in patients admitted with COVID-19. European Heart Journal, 42. https://doi.org/10.1093/eurheartj/ehab724.0103

Chicago

M Ambrosino, N Patel, L Panepinto, S Denduluri, C Lee, M Byers, Marielle Scherrer-Crosbie, Srinath Adusumalli, and Jordana B. Cohen. 2021. “The Role of Premorbid Transthoracic Echocardiogram in Identifying Adverse Clinical Outcomes in Patients Admitted with COVID-19.” European Heart Journal 42 (October). doi:10.1093/eurheartj/ehab724.0103.